Shoulder - Arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer

European Journal of Surgical Oncology

Volumn 28, Issue 7, 2002, Pages 705-710

  Haid, Anton ^a   Kuehn, T ^b   Konstantiniuk, P ^b   Koberle Wuhrer R ^a   Knauer, M ^a   Kreienberg, R ^c   Zimmermann, G ^a  

^a Landeskrankenhaus Feldkirch   (Austria)

^b Kreiskranhaus Gifhorn ^*  (Austria)

^c UNIVERSITY OF ULM MEDICAL SCHOOL   (Germany)

Author keywords

Axillary dissection; Breast cancer; Morbidity; Sentinel node biopsy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST SURGERY; CANCER STAGING; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE SEVERITY; DYSESTHESIA; FEMALE; HUMAN; HYPOALGESIA; JOINT LIMITATION; LYMPH NODE DISSECTION; LYMPHEDEMA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MUSCLE STRENGTH; NOCICEPTION; PAIN ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; SENTINEL LYMPH NODE BIOPSY; SHOULDER HAND SYNDROME; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY;

EID: 0036880666     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.2002.1327     Document Type: Article

References (28)

1. Carter CL, Allen C, Henderson DE. Relation of tumor size, lymph node status and survival in 24740 breast cases. Cancer 1989; 73: 505-8.
2. Fisher ER, Sass R, Fisher B: Pathologic findings from the National Surgical Adjuvant Project for Breast Cancers (protocol no. 4). Cancer 1984; 53: 712-23.
3. Cady B. A contemporary view of axillary dissection. Ann Surg 2000; 232: 8-9.
4. Greco M, Agresti R, Cascinelli N et al. Breast cancer patients treated without axillary surgery. Ann Surg 2000; 232: 1-7.
5. Morrow M. A survival benefit from axillary dissection: was Halsted correct? Ann Surg Oncol 1999; 6: 17-8.
6. Keramopoulos A, Tsionou C, Minaretzis D et al. Arm morbidity following treatment of breast cancer with total axillary dissection: a multivariate approach. Oncology 1993; 50: 445-9.
7. Hack FT, Cohen L, Katz J, Robson LS, Goss P. Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol 1999; 17: 143-9.
8. Kissin MW, Rovere Q, Easton D, Westbury G. Risk of lymphoedema following the treatment of breast cancer. Br J Surg 1986; 73: 580-4.
9. Kuehn T, Klauss W, Darsow M, et al. Long-term morbidity following axillary dissection in breast cancer patients - clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors. Breast Cancer Res Treat 2000; 64: 275-86.
10. Wührer-Köberle R, Haid A, Eiter H, Zimmermann G. Zur Morbidität der Axilladissektion beim Mammakarzinom. In: Waclawiczek HW, Menzel Ch, Hausmanninger H, Kogelnik HD, Wolf G (eds) Die interdisziplinäre kurative Behandlung des Mammakarzinoms. Was ist Standard, was ist Routine? Heidelberg Leipzig: Barth.
11. Haid A, Köberle-Wührer R, Knauer M et al. Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation. Breast Cancer Res Treat 2001; 2002; 73: 31-6.
12. Giuliano AE, Kirgan DM, Guenther MJ, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220: 391-401.
13. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans Sheila W, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995; 222: 394-401.
14. Haid A, Fritzsche H, Peschina W et al. Die Sentinel-Node-Biopsy beim Mammakarzinom: ein minimal invasives Verfahren zum exakten Staging der Axilla. Wien Klin Wochenschr 1999; 111: 219-25.
15. Giuliano AE, Haigh PI, Brennan MB et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 2000; 18: 2553-9.
16. Beets GL, Vonmeyenfeldt MF, Hess D et al. When can the sentinel node procedure be accepted as the standard of care? A multi-center validation study in a large region. Eur J Cancer 2000; 36(Suppl 5): 596.
17. Schrenk P, Riegler M, Shamiyeh A, Wayand W. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 2000; 88: 608-14.
18. Kuehn T, Klauss W, Darsow M et al. A new score for the assessment of postsurgery morbidity following axillary surgery. Breast Cancer Res Treat 2000; 64: 37.
19. Ivens D, Hoe AL, Podd TJ, Hamilton CR, Taylor I, Royle GT. Assessment of morbdity from complete axillary dissection. Br J Surg 1992; 66: 136-8.
20. Liljegren G, Holmberg L and The Uppsala-Örebro Breast Cancer Study Group. Arm morbidity after sector resection and axillary dissection with or without postoperative radiotherapy in breast cancer stage I. Results from a randomised trial. Eur J Cancer 1997; 33: 193-9.
21. Konstantiniuk P, Kowatsch E, Haid A, Bauer C, Steindorfer P. Das Multi Center Database Project (MCDBP). Acta Chir Austriaca 2001; 33: 200-1.
22. Sener S, Winchester D, Martz C et al. Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer 2001; 92: 748-52.
23. Erickson VS, Pearson ML, Ganz PA, Adams J. Arm edema in breast cancer patients. J Nat Cancer Inst 2001; 93: 96-111.
24. Schrenk P, Wayand W. Sentinel-node biopsy in axillary lymph-node staging for patients with multicentric breast cancer. Lancet 2001; 357: 122.
25. Haid A, Tausch C, Lang A et al. Is sentinel node biopsy reliable and indicated after preoperative chemotherapy? Cancer 2001; 92: 1080-4.
26. Borgstein P, Meijer S, Pijpers R, van Diest P. Functional lymphatic anatomy for sentinel node biopsy in breast cancer. Ann Surg 2000; 232: 81-9.
27. Carpenter R. Sentinel node biopsy should be introduced into routine practice before results of randomized trials are available. The Breast 2001; 10: 281-4.
28. National Surgical Adjuvant Breast and Bowle Project, Progress Report 1999, Pittsburgh, May 2000. Available from: URL: http// www.nsabp.pitt.edu/B-32.htm.